Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Reinvestment Rate
Starlake Bioscience Co Inc Zhaoqing Guangdong cash flow reinvestment rate. Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow Reinvestment Rate of 0.52x as of September 2025, reinvesting CN¥652.49 Million (capex CN¥652.49 Million ) from operating cash flow of CN¥1.25 Billion. See financial agility of Starlake Bioscience Co Inc Zhaoqing Guan to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Cash flow reinvestment rate of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. Historical reinvestment intensity for Starlake Bioscience Co Inc Zhaoqing Guangdong across 25 annual periods. Explore 600866 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Reinvestment Rate by Year (1998–2025)
Starlake Bioscience Co Inc Zhaoqing Guangdong cash flow reinvestment rate by year from 1998 to 2025. Year-by-year capital reinvestment analysis for Starlake Bioscience Co Inc Zhaoqing Guangdong. For the full cash flow conversion analysis, see Starlake Bioscience Co Inc Zhaoqing Guan operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.67x | CN¥2.16 Billion | CN¥1.29 Billion | CN¥2.04 Billion | ▲ +358.2% |
| 2024 | 0.36x | CN¥873.65 Million | CN¥2.40 Billion | CN¥638.50 Million | ▼ -40.2% |
| 2023 | 0.61x | CN¥1.23 Billion | CN¥2.03 Billion | CN¥375.83 Million | ▲ +26.3% |
| 2022 | 0.48x | CN¥802.34 Million | CN¥1.66 Billion | CN¥452.34 Million | ▼ -57.0% |
| 2021 | 1.12x | CN¥216.26 Million | CN¥192.63 Million | CN¥205.08 Million | ▼ -6.8% |
| 2020 | 1.20x | CN¥301.07 Million | CN¥249.99 Million | CN¥289.89 Million | ▲ +52.3% |
| 2019 | 0.79x | CN¥168.59 Million | CN¥213.17 Million | CN¥157.41 Million | ▲ +16.3% |
| 2018 | 0.68x | CN¥34.46 Million | CN¥50.69 Million | CN¥33.71 Million | ▼ -83.6% |
| 2017 | 4.14x | CN¥165.61 Million | CN¥40.05 Million | CN¥40.61 Million | ▲ +158.8% |
| 2016 | 1.60x | CN¥65.78 Million | CN¥41.17 Million | CN¥40.26 Million | ▼ -97.9% |
| 2015 | 75.72x | CN¥207.87 Million | CN¥2.75 Million | CN¥103.49 Million | ▲ +480.4% |
| 2011 | 13.05x | CN¥859.52 Million | CN¥65.88 Million | CN¥859.52 Million | ▲ +244.3% |
| 2010 | 3.79x | CN¥396.40 Million | CN¥104.63 Million | CN¥396.40 Million | ▲ +1816.9% |
| 2009 | 0.20x | CN¥62.60 Million | CN¥316.73 Million | CN¥62.60 Million | ▼ -41.1% |
| 2008 | 0.34x | CN¥49.97 Million | CN¥148.93 Million | CN¥49.97 Million | ▼ -63.1% |
| 2007 | 0.91x | CN¥74.90 Million | CN¥82.28 Million | CN¥74.90 Million | ▼ -58.6% |
| 2006 | 2.20x | CN¥77.37 Million | CN¥35.14 Million | CN¥77.37 Million | ▲ +47.8% |
| 2005 | 1.49x | CN¥69.77 Million | CN¥46.83 Million | CN¥69.77 Million | ▼ -80.4% |
| 2004 | 7.60x | CN¥220.76 Million | CN¥29.05 Million | CN¥220.76 Million | ▲ +932.9% |
| 2003 | 0.74x | CN¥110.12 Million | CN¥149.70 Million | CN¥110.12 Million | ▲ +52.8% |
| 2002 | 0.48x | CN¥88.18 Million | CN¥183.18 Million | CN¥88.18 Million | ▼ -62.1% |
| 2001 | 1.27x | CN¥77.35 Million | CN¥60.82 Million | CN¥77.35 Million | ▲ +76.9% |
| 2000 | 0.72x | CN¥67.16 Million | CN¥93.41 Million | CN¥67.16 Million | ▼ -52.1% |
| 1999 | 1.50x | CN¥79.45 Million | CN¥52.97 Million | CN¥79.45 Million | ▼ -6.2% |
| 1998 | 1.60x | CN¥113.73 Million | CN¥71.14 Million | CN¥113.73 Million | — |